United States · FDA National Drug Code directory
Piperacillin and Tazobactam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65219-256_1c3dc47a-2988-4d82-8d64-eeaeb6083eba
- Product NDC
- 65219-256
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- Piperacillin and Tazobactam
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171116
- Source listing expiry
- 20261231
Source-listed ingredients
- PIPERACILLIN SODIUM — 36 g/180mL
- TAZOBACTAM SODIUM — 4.5 g/180mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (65219-256-28) / 180 mL in 1 VIAL, PHARMACY BULK PACKAGE · 65219-256-28
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →